Survival in Agent Orange exposed and unexposed Vietnam era Veterans who were diagnosed with lymphoid malignancies

Abstract: Agent Orange (AO) was an herbicide mixture that was contaminated with the carcinogenic 2,3,7,8-tetrachlorodibenzo-p-dioxin. . Between 1962 and 1971, AO was widely sprayed throughout Vietnam and the demilitarized zone in Korea to destroy vegetation that hid or fed enemy forces during Operation Ranch Hand. Here we evaluate outcomes among Vietnam veterans who were diagnosed with lymphoid malignancies using data from the VA Central Cancer Registry. The study compared survival between AO-exposed and AO-unexposed veterans who served between 1/9/1962 and 5/7/74 and were diagnosed with lymphoid malignancies between 10/1/1998 and 12/31/2020. Patient and disease characteristics were summarized using descriptive statistics. The Chi-Square test and Wilcoxon rank sum tests were used to compare the association between categorical and continuous variables, respectively. In our study, AO-exposed veterans with DLBCL, HL, MCL, MZL, and NOS had longer median OS compared to those who were unexposed. AO-exposed patients with MCL, but not the other subtypes, had a higher median number of clinic visits 2 years prior to diagnosis. Our findings indicate that history of remote AO exposure does not define a distinct risk stratum for Vietnam era veterans with lymphoid malignancies. They also illustrate the need for prospective data collection beginning immediately after service.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.